One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...
Morning Overview on MSN
A single injection just slashed dangerous cholesterol by more than half for a full year — a gene-silencing shot aimed at the root of heart disease
Twice a year, a nurse slides a small needle under the skin of your upper arm. Thirty seconds later, you are done. No daily ...
Daily Mail on MSN
One-and-done injection can slash 'bad' cholesterol by 60 per cent
Experts say that the gene therapy could prove 'transformative' for patients by preventing future heart attacks or strokes.
1d
Can an injection prevent heart attacks? Eli Lilly’s gene-editing therapy cuts LDL cholesterol by 62%
A single infusion of experimental therapy may permanently switch off a cholesterol gene linked to heart attacks. And it could ...
The highest dose of a single injection reduced cholesterol levels by 62% in patients, according to Eli Lilly's recently ...
An experimental one-time gene editing therapy significantly lowered LDL cholesterol in an early-stage trial, raising hopes ...
MedPage Today on MSN
So Far, So Good for PCSK9-Targeting Gene Therapy in Hypercholesterolemia
Tweaked lipid nanoparticle delivery system showed early safety ...
Patients unable to control their cholesterol levels with medications may someday be able to lower their "bad" cholesterol with a shot, according to research presented at the American Heart Association ...
TARRYTOWN, N.Y., March 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) announced the U.S. Food & Drug Administration (FDA) has extended the approval of Praluent ® (alirocumab) as ...
While currently available PCSK9 inhibitor medications to lower cholesterol must be administered every few weeks by injection, a new, investigational PCSK9 inhibitor called recaticimab safely lowered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results